MATINAS BIOPHARMA HOLDINGS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Increase (Decrease) in Prepaid Expense and Other Assets of $306.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$35.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $341.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$141.00K, a 155.95% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$205.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$665.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$587.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$3.98M, a 194.90% decline from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $4.20M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $306.00K 10-Q · filed 2026-08-13 | $165.00K derived: sum of 3 quarters · filed 2026-08-13 | -$40.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $341.00K 10-Q · filed 2026-05-08 | $200.00K derived: sum of 2 quarters · filed 2026-05-08 | -$5.00K derived: sum of 3 quarters · filed 2026-05-08 | -$205.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$346.00K derived: sum of 2 quarters · filed 2026-03-31 | -$546.00K derived: sum of 3 quarters · filed 2026-08-13 | -$665.00K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$405.00K derived: sum of 2 quarters · filed 2026-08-13 | -$524.00K 10-Q · filed 2025-11-10 | -$272.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$319.00K 10-Q · filed 2026-08-13 | -$67.00K derived: sum of 3 quarters · filed 2026-08-13 | -$92.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$119.00K 10-Q · filed 2026-05-08 | $133.00K derived: sum of 2 quarters · filed 2026-05-08 | $108.00K derived: sum of 3 quarters · filed 2026-05-08 | -$1.10M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $227.00K derived: sum of 2 quarters · filed 2026-03-31 | -$980.00K derived: sum of 3 quarters · filed 2026-03-31 | -$587.00K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.23M derived: sum of 2 quarters · filed 2025-11-10 | -$839.00K 10-Q · filed 2025-11-10 | -$826.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$814.00K 10-Q · filed 2025-08-14 | -$801.00K derived: sum of 3 quarters · filed 2025-08-14 | -$515.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $393.00K 10-Q · filed 2025-05-15 | $406.00K derived: sum of 2 quarters · filed 2025-05-15 | $692.00K derived: sum of 3 quarters · filed 2025-05-15 | -$1.17M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $299.00K derived: sum of 2 quarters · filed 2025-04-15 | -$1.56M derived: sum of 3 quarters · filed 2025-04-15 | -$3.98M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $286.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$1.58M derived: sum of 2 quarters · filed 2024-11-13 | -$4.00M 10-Q · filed 2024-11-13 | -$2.48M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$4.28M 10-Q · filed 2024-08-14 | -$2.76M derived: sum of 3 quarters · filed 2024-08-14 | -$2.13M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$2.42M 10-Q · filed 2024-05-09 | -$899.00K derived: sum of 2 quarters · filed 2024-05-09 | -$273.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.90M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.15M derived: sum of 2 quarters · filed 2024-03-27 | $4.32M derived: sum of 3 quarters · filed 2024-03-27 | $4.20M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $626.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $2.80M derived: sum of 2 quarters · filed 2023-11-08 | $2.68M 10-Q · filed 2023-11-08 | $2.68M 10-Q · filed 2022-11-02 | $1.40M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.05M 10-Q · filed 2023-08-09 | $2.05M 10-Q · filed 2022-08-11 | $777.33K derived: sum of 3 quarters · filed 2023-08-09 | $2.44M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | -$122.00K 10-Q · filed 2023-05-10 | -$122.36K 10-Q · filed 2022-05-12 | -$1.39M derived: sum of 2 quarters · filed 2023-05-10 | $266.71K derived: sum of 3 quarters · filed 2023-05-10 | -$1.09M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $388.71K derived: sum of 2 quarters · filed 2023-03-15 | -$963.65K derived: sum of 3 quarters · filed 2023-03-15 | -$1.35M 10-K · filed 2023-03-15 | -$1.35M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $309.01K derived: sum of 2 quarters · filed 2022-11-02 | -$77.33K 10-Q · filed 2022-11-02 | $127.19K derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | -$1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.74M 10-Q · filed 2022-08-11 | -$1.53M derived: sum of 3 quarters · filed 2022-08-11 | -$265.78K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$386.35K 10-Q · filed 2022-05-12 | -$181.82K derived: sum of 2 quarters · filed 2022-05-12 | $1.09M derived: sum of 3 quarters · filed 2022-05-12 | -$455.59K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $204.53K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | $1.47M derived: sum of 2 quarters · filed 2022-03-11 | -$69.25K derived: sum of 3 quarters · filed 2022-03-11 | $611.40K 10-K/A · filed 2022-03-11 | ||||
| 2020-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$273.77K derived: sum of 2 quarters · filed 2021-11-08 | $406.87K 10-Q · filed 2021-11-08 | $981.87K derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$861.53K 10-Q · filed 2021-08-10 | -$286.53K derived: sum of 3 quarters · filed 2021-08-10 | $483.08K derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $680.64K 10-Q · filed 2021-05-10 | $1.26M derived: sum of 2 quarters · filed 2021-05-10 | $2.03M derived: sum of 3 quarters · filed 2021-05-10 | $2.13M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $1.34M derived: sum of 2 quarters · filed 2021-03-29 | $1.45M derived: sum of 3 quarters · filed 2021-03-29 | $1.36M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $769.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $873.23K derived: sum of 2 quarters · filed 2020-11-06 | $783.72K 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $103.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $14.10K 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | -$89.52K 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | -$349.67K 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |